Rochester, MN, United States of America

Eric W Mahlum

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2019.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eric W Mahlum: Innovator in Peptide-Mediated Drug Delivery

Introduction

Eric W Mahlum is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of biomedical research, particularly in the area of drug delivery systems. His innovative work focuses on overcoming the challenges associated with delivering therapeutic agents across the blood-brain barrier.

Latest Patents

Eric W Mahlum holds 1 patent for his invention titled "Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier." This patent describes peptides that function as carrier peptides, which can non-covalently bind to biologically active molecules or imaging agents. This innovative approach enhances the transport of these agents across the blood-brain barrier, potentially increasing their effectiveness in treating various neurological conditions.

Career Highlights

Eric is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research in peptide-mediated drug delivery. His work is pivotal in developing new therapeutic strategies that can improve patient outcomes in neurology.

Collaborations

Throughout his career, Eric has collaborated with esteemed colleagues, including Gobinda Sarkar and Joseph F Poduslo. These collaborations have further enriched his research and contributed to the advancement of innovative drug delivery systems.

Conclusion

Eric W Mahlum's contributions to peptide-mediated drug delivery represent a significant advancement in the field of biomedical research. His innovative approach to overcoming the blood-brain barrier holds promise for enhancing the effectiveness of therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…